George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
We are all hurting right now but the fairytale stories aren't always plain sailing. We shall see what happens. Some may have got out, newcomers will be here also. I am not going to suggest to anyone what to do, just make the right decisions for myself. I will be honest, at this point if a £10 a share offer came up I would take it. I wouldn't have said that 4 months ago. I believe it's going to be worth more than that longterm but wouldn't take a penny less. We have to do what's right for our own situations.
Docker, we all make our own choices. Hindsight is easy to make the judgements on but it goes both ways. I genuinely feel that this company has been unfairly treated. There are now many companies, and we know which ones, valued a lot more without producing bu**er all. We are still innovating and will continue to do so.
Crl, it comes down to faith or no faith. Lots of unknowns. For me, I have added to my holdings but can't afford to add any more. I have gone back over previous RNSs and GM is VERY conservative and cautious on everything. To me it reads that you want our products but we won't be bullied, but then I am a glass is half full person. Both sides of the argument have genuine grounds at this point. We will have a clearer picture in just a few weeks if nkt before.
Whilst Novacyt is technically a French company with uk subsidiaries then this is the problem. There is no benefit to the uk being the biggest market and this company being based in France. It goes back to being listed in UK only possibly US aswell with UK headquarters.
Novacyt planning 1 million tests a month on the LFTs. Odx has spare capacity of 1 million a month when uk government authorises a sovereign test. Approval was delayed at the same time as the delay on our test launch. Just saying.....
No, the share price went down because we lost our biggest contract. The market needs numerical proof that we can continue to do well without it. Those people aren't being employed just to sit around doing nothing. Once they have confirmation of this, and the new tests are released, then we will see a more realistic share price.
But yes I acknowledge that other companies have their share prices artificially inflated in comparison to Novacyt. Once again I put that down to Euronext, we shouldn't be there. Sorry, it's like a Mantra now. I am happy with the companies progress, just not WHERE we are.
SteveV, apologies if that is how it was meant. You have been a supporter and I acknowledge that. I just mean to say that Ekf for instance aren't as successful. Forget market cap, based on sales and margins let alone products to be launched it's like comparing jam today and marmite tomorrow.
SteveV. No comparison. Ekf, who you clearly seem to be championing, aren't making our kind of money. Comparing us to Avacta is insulting. We have been walking the walk for 15 months. For all those companies promising jam tomorrow, watch how it's done. How the market reacts is out of our control.
ValJu, closer to 50 than 40 but still able to kick Rs on the work front. Born on a saintly day, for security reasons won't say which 1. The age of the posters isn't relevant, just what is said and how you interpretate it. Wisdom can come from young and old. Youthful enthusiasm can be too dangerous, caution from the later years can be costly. Somewhere in between is just right. :)
I will put myself out there and say end of June. It is just my opinion and based on my interpretation of available information. We will know 1 way or another by then. Not ramping, everyone should make their own decisions based on available information. 1 persons opinion is just that. Plenty of positives before then, with 1 big unknown (tho in my view positive).
Covid: Indian variant cases in 86 council areas - Han**** - BBC News https://www.bbc.co.uk/news/uk-57150131